Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| ARUP Laboratories, |
RCV001001456 | SCV001158704 | pathogenic | not specified | 2019-06-07 | criteria provided, single submitter | clinical testing | The Hb Houston variant (HBB: c.383A>C; p.Gln128Pro, also known as Gln127Pro when numbered from the mature protein, rs33910569) is reported in the literature in at least one family affected with a dominant form of beta (+) thalassemia (Kazazian 1992, HbVar). Functional analyses show that the variant protein is highly unstable, and results in the degradation of hemoglobin tetramers, leading to the severe phenotype (Kazazian 1992). This variant is reported in ClinVar (Variation ID: 15409), and is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The glutamine at codon 128 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Additionally, other variants at this codon (Hb Dieppe, c.383A>G; p.Gln128Arg, Hb Brest, c.382C>A; Gln128Lys) have been reported in individuals with dominant beta (+) thalassemia (Girodon 1992, HbVar and references therein), and most dominant beta thalassemias are caused by variants in the same exon (Thein 1990). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar for Hb Houston: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=959&.cgifields=histD Girodon E et al. Rapid molecular characterization of mutations leading to unstable hemoglobin beta-chain variants. Ann Hematol. 1992 Oct;65(4):188-92. Kazazian HH Jr et al. Dominant thalassemia-like phenotypes associated with mutations in exon 3 of the beta-globin gene. Blood. 1992 Jun 1;79(11):3014-8. Thein S et al. Molecular basis for dominantly inherited inclusion body beta-thalassemia. Proc Natl Acad Sci U S A. 1990 May;87(10):3924-8. |
| OMIM | RCV000016664 | SCV000036932 | pathogenic | Beta-Houston-thalassemia | 1986-06-01 | no assertion criteria provided | literature only | |
| OMIM | RCV000022611 | SCV000043900 | pathogenic | Beta-plus-thalassemia, dominant | 1986-06-01 | no assertion criteria provided | literature only |